Microba, an Australian biotech company specialising in gut microbiome analysis, has received a $4.1 million investment from global precision medicine company Macrogen. [ + ]

Researchers are focused on a protein called α-synuclein as a target for a novel Parkinson's disease treatment. [ + ]

Cranberries are highly sought after for their tangy taste and the antioxidants they contain, but a new study provides evidence that they could also help in the fight against antibiotic resistance. [ + ]

Researchers have developed an assay that uses a drop of whole blood to provide rapid access to critical information associated with resistance to antimalarial drugs at the point of care. [ + ]

WA researchers have used rigorous contamination controls to confirm that exposure to bacteria begins in the womb, laying to rest the longstanding question of whether or not the womb is sterile. [ + ]

Australian Pharmaceutical Manufacturers has opened expanded operations in the suburb of Keysborough, allowing the company to increase exports and create 44 new local jobs. [ + ]

An international challenge compared the diagnostic skills of 511 physicians with 139 computer algorithms from 77 different machine learnings labs. [ + ]

Scientists have added a 'homing beacon' to tumours, in the form of an injectable hydrogel, that attracts chemotherapy medicines towards cancer cells while sparing their normal counterparts. [ + ]

Thermo Fisher Scientific has completed its acquisition of HighChem but terminated the agreement under which it would have acquired Gatan. [ + ]

Scientists have found that when zapped with an electrical field, live bacteria absorb dye molecules, causing the cells to light up and allowing them to be counted easily. [ + ]

AMS Instrumentation & Calibration has been appointed the exclusive distributor for the Bronkhorst range of thermal, Coriolis and ultrasonic flowmeters and controllers for low flow rates of gases and liquids in Australia and its territories. [ + ]

From protecting beer production against climate variability to gene editing, the TropAg conference will feature a variety of discussions from food scientists and innovators. [ + ]

In a large-scale, international study, 12.5 to 20% of patients who were given the drug on a daily basis experienced so-called sustained remission — a state that is almost like being cured. [ + ]

Two separate sets of European researchers have developed their own artificial intelligence methods to identify rare diseases, for which obtaining a definitive diagnosis can be difficult and time-consuming. [ + ]

Vaccitech has administered its pandemic universal influenza A vaccine MVA-NP+M1 (VTP-100) to the first participants in a Flu 010 study. [ + ]